Evidence map›Paper›PMID 20823267›Full record

ArticleMolecular and cellular biology2010

Thrombocytopenia in mice lacking the carboxy-terminal regulatory domain of the Ets transcription factor Fli1.

Omar Moussa, Amanda C LaRue, Romeo S Abangan, Christopher R Williams, Xian K Zhang, Masahiro Masuya, Yong Z Gong, Demetri D Spyropoulos, Makio Ogawa, Gary Gilkeson and 1 more

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. FLI1 and GATA1 governHaematologica · 2025
    Article
  2. Review
  3. A novel Boolean network inference strategy to model early hematopoiesis aging.Computational and structural biotechnology journal · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. SCL/TAL1-mediated transcriptional network enhances megakaryocytic specification of human embryonic stem cells.Molecular therapy : the journal of the American Society of Gene Therapy · 2015
    Article
  14. Article
  15. Review
  16. Mouse models of diseases of megakaryocyte and platelet homeostasis.Mammalian genome : official journal of the International Mammalian Genome Society · 2011
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Omar MoussaDepartment of Pathology and Laboratory Medicine, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA.
Amanda C LaRue
Romeo S Abangan
Christopher R Williams
Xian K Zhang
Masahiro Masuya
Yong Z Gong
Demetri D Spyropoulos
Makio Ogawa
Gary Gilkeson
Dennis K Watson
Medical University of South Carolina · US

Funding

Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI RAYMOND N. DUBOIS · 2009 to 2026
$42.7M
THE ROLE OF FLI1 IN CELLULAR DIFFERENTIATION AND DEVELOPMENTP01CA078582 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI WATSON, DENNIS K · 1998 to 2009
$9.1M
Molecular mechanisms of the impact of Fli-1 on lupusR01AR056670 · NIAMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ZHANG, XIAN · 2010 to 2014
$1.4M
Transdifferentiation Potential of Bone Marrow Stem CellsR01HL069123 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI OGAWA, MAKIO · 2003 to 2006
$1.3M
Impact of Fli-1 expression on lupus disease developmentK01AR051385 · NIAMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ZHANG, XIAN · 2005 to 2007
$368k
NCI NIH HHS P01 CA078582NCI NIH HHS P01-CA78582NCI NIH HHS P30 CA 138313NCI NIH HHS P30 CA138313NHLBI NIH HHS R01 HL069123NHLBI NIH HHS R01 HL69123NIAMS NIH HHS K01 AR051385NIAMS NIH HHS R01 AR056670
6 · The paper itself

Abstract

Targeted disruption of the Fli1 gene results in embryonic lethality. To dissect the roles of functional domains in Fli1, we recently generated mutant Fli1 mice that express a truncated Fli1 protein (Fli1(ΔCTA)) that lacks the carboxy-terminal regulatory (CTA) domain. Heterozygous Fli1(ΔCTA) mice are viable, while homozygous mice have reduced viability. Early postnatal lethality accounts for 30% survival of homozygotes to adulthood. The peripheral blood of these viable Fli1(ΔCTA)/Fli1(ΔCTA) homozygous mice has reduced platelet numbers. Platelet aggregation and activation were also impaired and bleeding times significantly prolonged in these mutant mice. Analysis of mRNA from total bone marrow and purified megakaryocytes from Fli1(ΔCTA)/Fli1(ΔCTA) mice revealed downregulation of genes associated with megakaroyctic development, including c-mpl, gpIIb, gpIV, gpIX, PF4, NF-E2, MafG, and Rab27B. While Fli1 and GATA-1 synergistically regulate the expression of multiple megakaryocytic genes, the level of GATA-1 present on a subset of these promoters is reduced in vivo in the Fli1(ΔCTA)/Fli1(ΔCTA) mice, providing a possible mechanism for the impared transcription observed. Collectively, these data showed for the first time a hemostatic defect associated with the loss of a specific functional domain of the transcription factor Fli1 and suggest previously unknown in vivo roles in megakaryocytic cell differentiation.

Indexed as

AnimalsBase SequenceCell DifferentiationDNA PrimersFemaleGATA1 Transcription FactorHeLa CellsHeterozygoteHomozygoteHumansMaleMegakaryocytesMiceMice, Inbred C57BLMice, KnockoutMice, Mutant StrainsDNA PrimersFli1 protein, mouseGata1 protein, mouseGATA1 Transcription FactorMutant ProteinsPeptide FragmentsProto-Oncogene Protein c-fli-1

Identifiers

PMID20823267
PMCPMC2953061
OpenAlexW1964610000

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.